Janney Montgomery Scott LLC Decreases Stock Holdings in SPDR S&P Biotech ETF $XBI

Janney Montgomery Scott LLC lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 29.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 47,720 shares of the exchange traded fund’s stock after selling 19,991 shares during the quarter. Janney Montgomery Scott LLC owned approximately 0.08% of SPDR S&P Biotech ETF worth $3,957,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. GAMMA Investing LLC increased its stake in shares of SPDR S&P Biotech ETF by 6,251.2% in the 1st quarter. GAMMA Investing LLC now owns 21,086 shares of the exchange traded fund’s stock worth $1,710,000 after acquiring an additional 20,754 shares during the last quarter. OLD National Bancorp IN boosted its holdings in SPDR S&P Biotech ETF by 5.7% during the 1st quarter. OLD National Bancorp IN now owns 5,284 shares of the exchange traded fund’s stock valued at $429,000 after acquiring an additional 285 shares during the period. Park Avenue Securities LLC purchased a new position in SPDR S&P Biotech ETF during the 1st quarter valued at about $268,000. IMC Chicago LLC purchased a new position in SPDR S&P Biotech ETF during the 1st quarter valued at about $6,022,000. Finally, Simplicity Wealth LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 1st quarter valued at about $360,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $103.68 on Wednesday. The stock has a 50-day simple moving average of $92.80 and a 200-day simple moving average of $85.38. The stock has a market capitalization of $6.15 billion, a PE ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.